In 2020, a study of hemoglobinopathies in newborns found the presence of Hb S, Hb D, and pathological genes for α- and β-thalassemia favoring the initiation of NBS for HGB [718], and a 2022 report detailed the data from a NBS study of GALT [719]. The gene discussed is GSTM1; the disease is hemoglobinopathy.